These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6601627)

  • 1. Analysis of chemotactic factor generation in C1q-deficient sera.
    Leyva-Cobián F; Clerici N
    Int Arch Allergy Appl Immunol; 1983; 71(2):151-5. PubMed ID: 6601627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
    van Dam AP; Hack CE
    Immunology; 1987 Jun; 61(2):105-10. PubMed ID: 3596635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway.
    Banda NK; Takahashi K; Wood AK; Holers VM; Arend WP
    J Immunol; 2007 Sep; 179(6):4101-9. PubMed ID: 17785849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE; Snyderman R; Kang AH
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q and immune complexes in liver cirrhosis sera.
    Yoshida H; Sato M; Watanabe S; Nishimaki T; Morito T; Kasukawa R; Nakai M
    Tohoku J Exp Med; 1983 May; 140(1):73-9. PubMed ID: 6603034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA; Woo P; Peters DK
    Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.
    Praz F; Roque Antunes Barreira MC; Lesavre P
    J Immunol Methods; 1982; 50(2):227-31. PubMed ID: 7045233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG binding to cytoskeletal intermediate filaments activates the complement cascade.
    Hansson GK; Lagerstedt E; Bengtsson A; Heideman M
    Exp Cell Res; 1987 Jun; 170(2):338-50. PubMed ID: 3496230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE).
    Uenaka A; Akimoto T; Aoki T; Tsuyuguchi I; Nagaki K
    Clin Exp Immunol; 1982 May; 48(2):353-8. PubMed ID: 6980744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement and IgG on zymosan opsonization.
    Cheson BD; Morris SE
    Int Arch Allergy Appl Immunol; 1981; 66(1):48-54. PubMed ID: 7263086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of neutrophil leucocytes in serum: possible role of C1q-containing immune complexes.
    Sturfelt G; Jonsson H; Hellmer G; Sjöholm AG
    Clin Exp Immunol; 1993 Aug; 93(2):237-41. PubMed ID: 8348750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.